ArticleNature medicine2025

BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells.

Fabian Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.